By Nathan Jeffay

Health Ministry-led research also shows teens who got their shots over four months ago only slightly better off than unvaccinated; hospitalizations among kids reportedly on rise.

Phase II trial of MesenCure among 30 patients with serious coronavirus cases shows almost all lived and had shorter hospital stays than controls, but expert says more data needed.

New data platform will allow doctors worldwide to input data from biopsies to find the best-matching immunotherapy for particular patients.

Tumors in mice lost half their size when injected with eosinophils, best known for inducing allergies; promising results also seen in human tumor cells in vitro.

Helpful bacteria fire ‘poisoned arrows’ at infection-causing microbes in Tel Aviv University lab; they ‘permeate a neighboring cell by brute force and release toxins into it’.

The variant was 27 times more likely to break through Pfizer protection from January-February and cause symptoms than it was to penetrate natural immunity from the same period.

Placebo study still to come, but inventor says medication ‘could be a game changer’ as most trial participants released from hospital in 5 days.

As the world talks of possible boosters, and with poorer countries struggling to get shots, the developer says pill could be a ‘game-changer.'

Poised to help many who have lost touch sensation to injury or amputation, tech feeds sensor’s signals to healthy nerves.

Scientists say they have successfully shut down pathways in animal brains, which will give neurobiologists opportunities to find treatments for human brain conditions.

Peer-reviewed research at Weizmann Institute is the most detailed insight into the MC4 hunger-controlling receptor.

When people test COVID positive, viral loads are 4 times lower if they’re vaccinated, according to first-of-its-kind Israeli research.

Leading in COVID-19 inoculation, the country’s small size, high efficiency, and a healthy dose of chutzpah has it on its way to herd immunity.

Small study saw improvement in 73% of multiple sclerosis patients who got spinal injection containing treatment made from their own cells.

Hadassah hospital gave 3 people a new drug made from antibodies from people who had had coronavirus; they are all now home after an ‘astonishing’ recovery.